Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Sherer

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Seminars in Arthritis and Rheumatism|May 11, 2000
Intravenous immunoglobulin treatment of lupus nephritisY Levy, Y Sherer, J George, et al.
International Archives of Allergy and Immunology|August 7, 1999
Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulinY Levy, Y Sherer, J George, et al.
Clinical and Experimental Rheumatology|July 1, 2008
Bacterial triggers and autoimmune rheumatic diseasesH J Girschick, L Guilherme, R D Inman, et al.
Lupus|December 22, 1999
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic responseY Levy, Y Sherer, A Ahmed, et al.
Clinical and Experimental Rheumatology|December 9, 1998
Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. European Concerted Action on the Immunogenetics of SLEM Galeazzi, F Bellisai, G D Sebastiani, et al.
Lupus|November 3, 2009
Common infectious agents prevalence in antiphospholipid syndromeH Zinger, Y Sherer, G Goddard, et al.
Cardiology|June 1, 2001
Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodiesY Sherer, A Tenenbaum, S Praprotnik, et al.
Seminars in Arthritis and Rheumatism|December 20, 1999
Frontiers of SLE: review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, April 20-25, 1998Y Shoenfeld, D Alarcon-Segovia, D Buskila, et al.
Autoimmunity|October 31, 2001
Anti-endothelial cell antibodies (AECA) in systemic sclerosis--increased sensitivity using different endothelial cell substrates and association with other autoantibodiesY Renaudineau, E Grunebaum, I Krause, et al.
Annals of the Rheumatic Diseases|October 30, 2003
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosusA Doria, Y Shoenfeld, R Wu, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Seminars in Arthritis and Rheumatism|May 11, 2000
Intravenous immunoglobulin treatment of lupus nephritisY Levy, Y Sherer, J George, et al.
International Archives of Allergy and Immunology|August 7, 1999
Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulinY Levy, Y Sherer, J George, et al.
Clinical and Experimental Rheumatology|July 1, 2008
Bacterial triggers and autoimmune rheumatic diseasesH J Girschick, L Guilherme, R D Inman, et al.
Lupus|December 22, 1999
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic responseY Levy, Y Sherer, A Ahmed, et al.
Clinical and Experimental Rheumatology|December 9, 1998
Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. European Concerted Action on the Immunogenetics of SLEM Galeazzi, F Bellisai, G D Sebastiani, et al.
Lupus|November 3, 2009
Common infectious agents prevalence in antiphospholipid syndromeH Zinger, Y Sherer, G Goddard, et al.
Cardiology|June 1, 2001
Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodiesY Sherer, A Tenenbaum, S Praprotnik, et al.
Seminars in Arthritis and Rheumatism|December 20, 1999
Frontiers of SLE: review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, April 20-25, 1998Y Shoenfeld, D Alarcon-Segovia, D Buskila, et al.
Autoimmunity|October 31, 2001
Anti-endothelial cell antibodies (AECA) in systemic sclerosis--increased sensitivity using different endothelial cell substrates and association with other autoantibodiesY Renaudineau, E Grunebaum, I Krause, et al.
Annals of the Rheumatic Diseases|October 30, 2003
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosusA Doria, Y Shoenfeld, R Wu, et al.
Pageof 10